These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21392144)

  • 1. Self-reported level of and factors influencing the compliance to desferrioxamine therapy in multitransfused thalassaemias.
    Lee WS; Toh TH; Chai PF; Soo TL
    J Paediatr Child Health; 2011 Aug; 47(8):535-40. PubMed ID: 21392144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment.
    Dahlui M; Hishamshah MI; Rahman AJ; Aljunid SM
    Singapore Med J; 2009 Aug; 50(8):794-9. PubMed ID: 19710979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
    Shalitin S; Carmi D; Weintrob N; Phillip M; Miskin H; Kornreich L; Zilber R; Yaniv I; Tamary H
    Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose intravenous desferrioxamine (DFO) delivery in four thalassemic patients allergic to subcutaneous DFO administration.
    Lombardo T; Ferro G; Frontini V; Percolla S
    Am J Hematol; 1996 Jan; 51(1):90-2. PubMed ID: 8571945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observational study comparing long-term safety and efficacy of Deferasirox with Desferrioxamine therapy in chelation-naïve children with transfusional iron overload.
    Aydinok Y; Unal S; Oymak Y; Vergin C; Türker ZD; Yildiz D; Yesilipek A
    Eur J Haematol; 2012 May; 88(5):431-8. PubMed ID: 22335829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beliefs about chelation among thalassemia patients.
    Trachtenberg FL; Mednick L; Kwiatkowski JL; Neufeld EJ; Haines D; Pakbaz Z; Thompson AA; Quinn CT; Grady R; Sobota A; Olivieri N; Horne R; Yamashita R;
    Health Qual Life Outcomes; 2012 Dec; 10():148. PubMed ID: 23216870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensification of chelating-therapy in patients with thalassemia major.
    Laws HJ; Göbel U; Christaras A; Janssen G
    Klin Padiatr; 2005; 217(3):120-5. PubMed ID: 15858702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia.
    Pakbaz Z; Fischer R; Treadwell M; Yamashita R; Fung EB; Calvelli L; Quirolo K; Foote D; Harmatz P; Vichinsky EP
    Ann N Y Acad Sci; 2005; 1054():486-91. PubMed ID: 16339703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous chelation therapy during transplantation for thalassemia.
    Gaziev D; Giardini C; Angelucci E; Polchi P; Galimberti M; Baronciani D; Erer B; Maiello A; Lucarelli G
    Haematologica; 1995; 80(4):300-4. PubMed ID: 7590497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of two years of deferoxamine therapy on iron balance, ferritin, liver and heart in patients with thalassemia major].
    Flückiger A; Imbach P; Pfenninger E; Stocker F; Töndury P; Wagner HP; Weber J; Zuppinger K
    Helv Paediatr Acta; 1985 Sep; 40(4):293-304. PubMed ID: 4077563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chelation therapy with desferrioxamine does not normalize ferritin level but attenuates oxidative damage and improves total antioxidant level in Malaysian Chinese beta-thalassaemia major patients.
    Kuppusamy UR; Tan JA
    West Indian Med J; 2011 Jan; 60(1):3-8. PubMed ID: 21809703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron chelation therapy in Upper Egyptian transfusion-dependent pediatric homozygous beta-thalassemia major: impact on serum L-carnitine/free fatty acids, osteoprotegerin/the soluble receptor activator of nuclear factor-kappabeta ligand systems, and bone mineral density.
    Hamed EA; Mohamed NA; El-Metwally TH; Kamal MM
    J Pediatr Hematol Oncol; 2010 May; 32(4):267-73. PubMed ID: 20445416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term intravenous deferoxamine treatment for noncompliant transfusion-dependent beta-thalassemia patients.
    Tamary H; Goshen J; Carmi D; Yaniv I; Kaplinsky C; Cohen IJ; Zaizov R
    Isr J Med Sci; 1994 Aug; 30(8):658-64. PubMed ID: 8045754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desferrioxamine induced urinary iron excretion in thalassemia.
    Dubey AP; Kumar S; Choudhury P; Talukdar B; Puri RK
    Indian Pediatr; 1993 Jun; 30(6):775-8. PubMed ID: 8132258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth velocity in transfusion dependent prepubertal thalassemia patients: results from a thalassemia center in Malaysia.
    Hamidah A; Arini MI; Zarina AL; Zulkifli SZ; Jamal R
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):900-5. PubMed ID: 19058587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous bolus injection of deferoxamine is an alternative method to subcutaneous continuous infusion.
    Yarali N; Fişgin T; Duru F; Kara A; Ecin N; Fitoz S; Erden I
    J Pediatr Hematol Oncol; 2006 Jan; 28(1):11-6. PubMed ID: 16394886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful desensitization of a case with desferrioxamine hypersensitivity.
    Gülen F; Demir E; Tanaç R; Aydinok Y; Gulen H; Yenigün A; Can D
    Minerva Pediatr; 2006 Dec; 58(6):571-4. PubMed ID: 17093379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of iron overload in thalassemia].
    Piga A; Davico S; Magliano M; Luzzatto L; Sandri A; Gabutti V
    Pediatr Med Chir; 1986; 8(1):9-13. PubMed ID: 3725619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed decrease in serum ferritin in polytransfused children with thalassemia major after continuous subcutaneous infusions of desferrioxamine.
    Schettini F; Mautone A; Cavallo L; Altomare M; Montagna O; Dell'Edera L
    Acta Haematol; 1981; 66(2):96-101. PubMed ID: 6794319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum ferritin concentrations in transfusion dependent beta-thalassaemia.
    George E; Wong HB; George R; Ariffin WA
    Singapore Med J; 1994 Feb; 35(1):62-4. PubMed ID: 8009283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.